经导管二尖瓣介入治疗。
Transcatheter mitral valve intervention.
作者信息
Ganatra Rea, Smith Robert
机构信息
Internal Medicine Trainee Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Hill End Road, Harefield, UB9 6JH.
Consultant Cardiologist Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, Hill End Road, Harefield, UB9 6JH.
出版信息
Br J Cardiol. 2021 Nov 30;28(4):51. doi: 10.5837/bjc.2021.051. eCollection 2021.
Mitral regurgitation is a common valvular heart disorder increasing with age. Many patients are ineligible for mitral valve surgery due to their age and other comorbidities. Left untreated, patients develop severe disease with a poor prognosis. The development of lower risk percutaneous mitral valve interventions has helped meet the needs of this previously untreated patient group. This review explores the recent and more established developments that have expanded the armamentarium for transcatheter mitral valve intervention.
二尖瓣反流是一种常见的心脏瓣膜疾病，其发病率随年龄增长而增加。许多患者由于年龄和其他合并症而不符合二尖瓣手术的条件。如果不进行治疗，患者会发展为严重疾病，预后较差。低风险经皮二尖瓣介入治疗的发展有助于满足这一以前未得到治疗的患者群体的需求。本综述探讨了最近以及更为成熟的进展，这些进展扩大了经导管二尖瓣介入治疗的手段。
Zotero 插件